AAO, November 14-17, 2015, Las Vegas (CA), US

GenSight Biologics participated to AAO in Las vegas, US.

Jose Alain Sahel MD, CHNO Institut de la Vision, GenSight-Biologics Share Holder and Consultant, gave an oral presentation (Abstract ID: 30043757) : A Recombinant AAV2/2 Vector Carrying the Wild-Type ND4 Gene for the Treatment of Leber Hereditary Optic Neuropathy: Results of a First-in-Human Study on Tuesday, November 17, 2015, 9:30 AM to 9:40 AM, location Bassano 2701.